Items where Author or Editor is "Herrlinger, Ulrich" - Kölner UniversitätsPublikationsServer

Group by: Item Type | Date | No Grouping

Number of items: 36.

Journal Article

Ceccon, Garry, Lohmann, Philipp, Tscherpel, Caroline, Dunkl, Veronika, Rapp, Marion, Stoffels, Gabriele, Herrlinger, Ulrich, Rosen, Jurij, Wollring, Michael, Shah, Nadim J., Fink, Gereon R., Langen, Karl-Josef and Galldiks, Norbert ORCID: 0000-0002-2485-1796 (2018). EARLY TREATMENT RESPONSE ASSESSMENT USING O-(2-F-18-FLUOROETHYL)-L-TYROSINE (FET) PET COMPARED TO MRI IN MALIGNANT GLIOMAS TREATED WITH ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY. Neuro-Oncology, 20. S. 193 - 194. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Ceccon, Garry, Lohmann, Philipp ORCID: 0000-0002-5360-046X, Werner, Jan-Michael ORCID: 0000-0001-7147-4594, Tscherpel, Caroline, Dunkl, Veronika, Stoffels, Gabriele, Rosen, Jurij, Rapp, Marion, Sabel, Michael, Herrlinger, Ulrich, Schaefer, Niklas, Shah, Nadim J., Fink, Gereon R. ORCID: 0000-0002-8230-1856, Langen, Karl-Josef ORCID: 0000-0003-1101-5075 and Galldiks, Norbert (2021). Early Treatment Response Assessment Using F-18-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy. J. Nucl. Med., 62 (7). S. 918 - 926. RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667

Di Tacchio, Mariangela, Macas, Jadranka, Weissenberger, Jakob, Sommer, Kathleen, Baehr, Oliver, Steinbach, Joachim P., Senft, Christian, Seifert, Volker, Glas, Martin, Herrlinger, Ulrich, Krex, Dietmar, Meinhardt, Matthias, Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Timmer, Marco, Goldbrunner, Roland, Deckert, Martina, Scheel, Andreas H., Buettner, Reinhard, Grauer, Oliver M., Schittenhelm, Jens, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Harter, Patrick N., Guenther, Stefan, Devraj, Kavi, Plate, Karl H. and Reiss, Yvonne (2019). Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF. Cancer Immunol. Res., 7 (12). S. 1910 - 1928. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 2326-6074

Galldiks, Norbert ORCID: 0000-0002-2485-1796, Dunkl, Veronika, Stoffels, Gabriele ORCID: 0000-0001-7114-1941, Hutterer, Markus, Rapp, Marion, Sabel, Michael, Reifenberger, Guido, Kebir, Sied, Dorn, Franziska ORCID: 0000-0001-9093-8307, Blau, Tobias, Herrlinger, Ulrich, Hau, Peter ORCID: 0000-0003-3894-5053, Ruge, Maximilian I., Kocher, Martin, Goldbrunner, Roland, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Drzezga, Alexander, Schmidt, Matthias and Langen, Karl-Josef ORCID: 0000-0003-1101-5075 (2015). Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[F-18]fluoroethyl)-L-tyrosine PET. Eur. J. Nucl. Med. Mol. Imaging, 42 (5). S. 685 - 696. NEW YORK: SPRINGER. ISSN 1619-7089

Golla, Heidrun, Ahmad, Maryam Ale, Galushko, Maren, Hampl, Juergen, Maarouf, Mohammad, Schroeter, Michael, Herrlinger, Ulrich, Hellmich, Martin and Voltz, Raymond (2014). Glioblastoma multiforme from diagnosis to death: a prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs. Support. Care Cancer, 22 (12). S. 3341 - 3353. NEW YORK: SPRINGER. ISSN 1433-7339

Golla, Heidrun, Nettekoven, Charlotte ORCID: 0000-0002-8944-4681, Bausewein, Claudia, Tonn, Joerg-Christian, Thon, Niklas, Feddersen, Berend, Schnell, Oliver, Boehlke, Christopher ORCID: 0000-0002-6985-0201, Becker, Gerhild, Rolke, Roman, Clusmann, Hans, Herrlinger, Ulrich, Radbruch, Lukas, Vatter, Hartmut, Gueresir, Erdem, Stock, Stephanie, Mueller, Dirk, Civello, Daniele, Papachristou, Irini, Hellmich, Martin, Hamacher, Stefanie ORCID: 0000-0003-2158-9101, Voltz, Raymond and Goldbrunner, Roland (2020). Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol. BMJ Open, 10 (1). LONDON: BMJ PUBLISHING GROUP. ISSN 2044-6055

Heinzel, Alexander, Dedic, Daniela, Galldiks, Norbert, Lohmann, Philipp ORCID: 0000-0002-5360-046X, Stoffels, Gabriele, Filss, Christian P., Kocher, Martin, Migliorini, Filippo ORCID: 0000-0001-7220-1221, Dillen, Kim N. H., Geisler, Stefanie, Stegmayr, Carina, Willuweit, Antje, Sabel, Michael ORCID: 0009-0000-1485-7820, Rapp, Marion, Eble, Michael J., Piroth, Marc, Clusmann, Hans, Delev, Daniel, Bauer, Elena K., Ceccon, Garry, Dunkl, Veronika, Rosen, Jurij, Tscherpel, Caroline, Werner, Jan-Michael, Ruge, Maximilian I., Goldbrunner, Roland, Hampl, Jurgen, Weiss Lucas, Carolin, Herrlinger, Ulrich, Maurer, Gabriele D., Steinbach, Joachim P., Mauler, Joerg, Worthoff, Wieland A., Neumaier, Bernd N., Lerche, Christoph, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Shah, Nadim Jon, Mottaghy, Felix M. and Langen, Karl-Josef (2022). Two Decades of Brain Tumour Imaging with O-(2-[F-18]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Julich Experience. Cancers, 14 (14). BASEL: MDPI. ISSN 2072-6694

Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Kohnen, Ralf, Urbach, Horst, Stummer, Walter and Glas, Martin (2014). QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Haenel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Ruediger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tuettenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter and Glas, Martin (2016). Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. J. Clin. Oncol., 34 (14). S. 1611 - 1623. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Herrlinger, Ulrich, Schaefer, Nildas, Steinbach, Joachim Peter, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Braun, Christian, Kohnen, Ralf, Leutgeb, Barbara, Belka, Claus, Urbach, Horst, Stummer, Walter and Gies, Martin (2014). Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim, Schlegel, Uwe, Sabel, Michael, Hau, Peter, Kortman, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Tabatabai, Ghazaleh, Ringel, Florian, Schmidt-Graf, Friederike, Brehmer, Stefanie, Weyerbrock, Astrid, Bullinger, Lars, Vajkoczy, Peter, Vatter, Hartmut, Schaefer, Niklas, Kebir, Sied, Weller, Johannes, Stummer, Walter, Simon, Matthias, Keil, Vera ORCID: 0000-0001-8699-3506, Nelles, Michael, Fimmers, Rolf, Pietsch, Torsten, Hattingen, Elke, Coch, Christoph and Glas, Martin (2017). PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial. Neuro-Oncology, 19. S. 13 - 15. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Herrlinger, Ulrich, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter ORCID: 0000-0003-3894-5053, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schaefer, Niklas, Kebir, Sied, Weller, Johannes ORCID: 0000-0001-5818-5392, Schaub, Christina, Stummer, Walter, Tonn, Joerg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang ORCID: 0000-0002-6171-634X, Weller, Michael, Fimmers, Rolf, Schmid, Matthias ORCID: 0000-0002-0788-0317, Hattingen, Elke ORCID: 0000-0002-8392-9004, Pietsch, Torsten, Coch, Christoph and Glas, Martin (2019). Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. Lancet, 393 (10172). S. 678 - 689. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Kebir, Sied, Fimmers, Rolf, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Schaefer, Niklas, Mack, Frederic, Schaub, Christina, Stuplich, Moritz, Niessen, Michael, Tzaridis, Theophilos, Simon, Matthias, Stoffels, Gabriele ORCID: 0000-0001-7114-1941, Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Scheffler, Bjoern, Glas, Martin and Herrlinger, Ulrich (2016). Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[F-18]fluoroethyl)-L-Tyrosine PET. Clin. Cancer Res., 22 (9). S. 2190 - 2197. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Kebir, Sied, Hattingen, Elke, Schaub, Christina, Schafer, Niklas, Steinbach, Joachim, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Tzaridis, Theophilos, Baehr, Oliver, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich (2016). EFFECT OF AGE ON OUTCOME IN THE GLARIUS TRIAL. Neuro-Oncology, 18. S. 5 - 6. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Kebir, Sied, Niessen, Michael, Kellner, Alexandra, Tschuschke, Volker, Herrlinger, Ulrich and Glas, Martin (2017). ACTIVE COPING STRATEGIES ARE ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: A PROSPECTIVE STUDY. Neuro-Oncology, 19. S. 208 - 209. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Kebir, Sied, Rauschenbach, Laurel, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Schlaak, Max, Hattingen, Elke ORCID: 0000-0002-8392-9004, Landsberg, Jennifer ORCID: 0000-0001-8029-3883, Bundschuh, Ralph A., Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Scheffler, Bjoern, Herrlinger, Ulrich and Glas, Martin (2016). Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases. Neuro-Oncology, 18 (10). S. 1462 - 1465. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Weller, Johannes ORCID: 0000-0001-5818-5392, Mack, Frederic, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Baehr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich (2019). Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. J. Neuro-Oncol., 144 (3). S. 501 - 510. NEW YORK: SPRINGER. ISSN 1573-7373

Kebir, Sied, Schmidt, Teresa, Weber, Matthias, Lazaridis, Lazaros, Galldiks, Norbert, Langen, Karl-Josef, Kleinschnitz, Christoph, Hattingen, Elke, Herrlinger, Ulrich, Lohmann, Philipp and Glas, Martin (2020). MACHINE LEARNING-BASED EVALUATION OF STATIC AND DYNAMIC FET-PET FOR THE DETECTION OF PSEUDOPROGRESSION IN PATIENTS WITH IDH-WILDTYPE GLIOBLASTOMA. Neuro-Oncology, 22. S. 149 - 152. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Kebir, Sied, Schmidt, Teresa, Weber, Matthias, Lazaridis, Lazaros, Galldiks, Norbert, Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Kleinschnitz, Christoph, Hattingen, Elke, Herrlinger, Ulrich, Lohmann, Philipp ORCID: 0000-0002-5360-046X and Glas, Martin (2020). A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma. Cancers, 12 (11). BASEL: MDPI. ISSN 2072-6694

Kebir, Sied, Stummer, Walter, Steinbach, Joachim, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Proescholdt, Martin, Vatter, Hartmut, Herrlinger, Ulrich and Glas, Martin (2017). COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA: RESULTS FROM THE GLARIUS TRIAL. Neuro-Oncology, 19. S. 235 - 236. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Rosen, Jurij, Ceccon, Garry, Bauer, Elena K., Werner, Jan-Michael ORCID: 0000-0001-7147-4594, Tscherpel, Caroline, Dunkl, Veronika ORCID: 0000-0001-6885-7666, Rapp, Marion, Sabel, Michael ORCID: 0009-0000-1485-7820, Herrlinger, Ulrich, Heinzel, Alexander, Schaefer, Niklas, Ruge, Maximilian, Goldbrunner, Roland, Stoffels, Gabriele, Kabbasch, Christoph, Fink, Gereon R., Langen, Karl-Josef and Galldiks, Norbert (2022). Cost Effectiveness of F-18-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy. J. Nucl. Med., 63 (11). S. 1677 - 1683. RESTON: SOC NUCLEAR MEDICINE INC. ISSN 1535-5667

Schaefer, Niklas, Proescholdt, Martin, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Grauer, Oliver, Goldbrunner, Roland, Friedrich, Franziska, Rohde, veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Grau, Stefan, Haenel, Mathias, Schnell, Oliver, Krex, Dietmar, Vajkoczy, Peter, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Mack, Frederic, Schaub, Christina, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Niessen, Michael, Kebir, Sied, Leutgeb, Barbara, Urbach, Horst, Belka, Claus, Stummer, Walter, Glas, Martin and Herrlinger, Ulrich (2018). Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro-Oncology, 20 (7). S. 975 - 986. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Baehr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich and Glas, Martin (2018). Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. J. Cancer Res. Clin. Oncol., 144 (8). S. 1581 - 1590. NEW YORK: SPRINGER. ISSN 1432-1335

Scholz, Alexander, Harter, Patrick N. ORCID: 0000-0001-5530-6910, Cremer, Sebastian, Yalcin, Burak H., Gurnik, Stefanie, Yamaji, Maiko, Di Tacchio, Mariangela, Sommer, Kathleen, Baumgarten, Peter, Baehr, Oliver, Steinbach, Joachim P., Trojan, Joerg, Glas, Martin, Herrlinger, Ulrich, Krex, Dietmar, Meinhardt, Matthias, Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Timmer, Marco, Goldbrunner, Roland, Deckert, Martina, Braun, Christian, Schittenhelm, Jens, Frueh, Jochen T., Ullrich, Evelyn ORCID: 0000-0001-8530-1192, Mittelbronn, Michel, Plate, Karl H. and Reiss, Yvonne (2016). Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol. Med., 8 (1). S. 39 - 58. HOBOKEN: WILEY-BLACKWELL. ISSN 1757-4684

Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Liu, Shu, Surmann, Kristin, Babatz, Felix, Salazar, Manuela Gesell, Voelker, Uwe, Hallek, Michael, Herrlinger, Ulrich, Vorberg, Ina ORCID: 0000-0003-0583-4015, Coch, Christoph, Reiners, Katrin S. and Hartmann, Gunther (2021). Extracellular Vesicle Separation Techniques Impact Results from Human Blood Samples: Considerations for Diagnostic Applications. Int. J. Mol. Sci., 22 (17). BASEL: MDPI. ISSN 1422-0067

Tzaridis, Theophilos, Reiners, Katrin S., Weller, Johannes, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Schaefer, Niklas, Schaub, Christina, Hallek, Michael, Scheffler, Bjoern, Glas, Martin, Herrlinger, Ulrich, Wild, Stefan, Coch, Christoph and Hartmann, Gunther (2020). Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature. Int. J. Mol. Sci., 21 (19). BASEL: MDPI. ISSN 1422-0067

Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Schaefer, Niklas, Weller, Johannes, Steinbach, Joachim-Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Joerg-Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich and Felsberg, Joerg . MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial. Int. J. Cancer. HOBOKEN: WILEY. ISSN 1097-0215

Tzaridis, Theophilos, Weller, Johannes, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Schaefer, Niklas, Schaub, Christina, Hallek, Michael, Scheffler, Bjoern, Glas, Martin, Hartmann, Gunther, Herrlinger, Ulrich, Wild, Stefan, Coch, Christoph and Reiners, Katrin (2020). ANALYSIS OF SERUM MIRNA IN GLIOBLASTOMA PATIENTS: TARGETED ENRICHMENT OF EXTRACELLULAR VESICLES ENHANCES SPECIFICITY FOR PROGNOSTIC SIGNATURE. Neuro-Oncology, 22. S. 10 - 11. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Weller, Johannes, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Shakeri, Farhad ORCID: 0000-0003-1161-1942, Schaub, Christina, Hau, Peter, Buness, Andreas, Schlegel, Uwe, Steinbach, Joachim-Peter, Seidel, Clemens, Goldbrunner, Roland, Schaefer, Niklas, Wechsler-Reya, Robert J., Hallek, Michael ORCID: 0000-0002-7425-4455, Scheffler, Bjoern, Glas, Martin, Haeberle, Lothar, Herrlinger, Ulrich, Coch, Christoph, Reiners, Katrin S. and Hartmann, Gunther (2023). A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression. Int. J. Cancer, 152 (2). S. 308 - 320. HOBOKEN: WILEY. ISSN 1097-0215

Weller, Johannes ORCID: 0000-0001-5818-5392, Schaefer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Schlegel, Uwe, Sabel, Michael ORCID: 0009-0000-1485-7820, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Pietsch, Torsten, Tzaridis, Theophilos, Zeyen, Thomas, Borger, Valeri, Guresir, Erdem, Vatter, Hartmut, Herrlinger, Ulrich and Schneider, Matthias (2022). Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS. J. Neuro-Oncol., 159 (1). S. 95 - 102. NEW YORK: SPRINGER. ISSN 1573-7373

Weller, Johannes ORCID: 0000-0001-5818-5392, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Brehmer, Stefanie, Bullinger, Lars, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Schaub, Christina, Kebir, Sied, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich and Schaefer, Niklas (2019). Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol., 20 (10). S. 1444 - 1454. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Weller, Johannes, Tzaridis, Theophilos, Steinbach, Joachim, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh, Bullinger, Lars, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Schaub, Christina, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Matthias, Schmid, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich and Schaefer, Niklas (2018). QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA. Neuro-Oncology, 20. S. 218 - 220. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Werner, Jan-Michael, Ceccon, Garry, Weller, Johannes, Schaub, Christina, Tscherpel, Caroline, Lohmann, Philipp, Bauer, Elena, Schaefer, Niklas, Stoffels, Gabriele, Kabbasch, Christoph, Baues, Christian, Marnitz, Simone, Fink, Gereon R., Langen, Karl-Josef, Herrlinger, Ulrich and Galldiks, Norbert (2020). DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET. Neuro-Oncology, 22. S. 152 - 155. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Werner, Jan-Michael ORCID: 0000-0001-7147-4594, Weller, Johannes, Ceccon, Garry, Schaub, Christina, Tscherpel, Caroline, Lohmann, Philipp ORCID: 0000-0002-5360-046X, Bauer, Elena K., Schaefer, Niklas, Stoffels, Gabriele, Baues, Christian, Celik, Eren, Marnitz, Simone, Kabbasch, Christoph, Gielen, Gerrit H., Fink, Gereon R. ORCID: 0000-0002-8230-1856, Langen, Karl-Josef, Herrlinger, Ulrich and Galldiks, Norbert (2021). Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET. Clin. Cancer Res., 27 (13). S. 3704 - 3714. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael ORCID: 0009-0000-1485-7820, Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Gueresir, Erdem, Schmid, Matthias ORCID: 0000-0002-0788-0317, Schuss, Patrick ORCID: 0000-0002-5806-2576, Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank ORCID: 0000-0003-4892-6104, Herrlinger, Ulrich and Schneider, Matthias (2022). Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. Trials, 23 (1). LONDON: BMC. ISSN 1745-6215

This list was generated on Sun Nov 24 01:29:38 2024 CET.

Export as	Atom RSS 1.0 RSS 2.0